<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>pediatrics</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>pediatrics | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases
Authors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/pediatrics/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="pediatrics" />
<meta property="og:description" content="Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases
Authors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/pediatrics/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-08-09T10:39:33+00:00" />
<meta property="article:modified_time" content="2023-08-09T10:39:33+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="pediatrics"/>
<meta name="twitter:description" content="Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases
Authors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "pediatrics",
      "item": "https://trxiv.yorks0n.com/posts/pediatrics/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "pediatrics",
  "name": "pediatrics",
  "description": "Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases\nAuthors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M.",
  "keywords": [
    
  ],
  "articleBody": " Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases\nAuthors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M.; Vermont, C.; von Both, U.; Yeung, S.; Zavadska, D.; Coin, L. J. M.; Cunnington, A. J.; Herberg, J.; Levin, M.; Kaforou, M.; Hamilton, M. S.; PERFORM Consortium, ; DIAMONDS Consortium, ; UK KD Genetic Consortium, Score: 14.6, Published: 2023-07-31 DOI: 10.1101/2023.07.28.23293197\nBackgroundMultisystem inflammatory syndrome in children (MIS-C) is a rare but serious hyperinflammatory complication following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The mechanisms underpinning the pathophysiology of MIS-C are poorly understood. Moreover, clinically distinguishing MIS-C from other childhood infectious and inflammatory conditions, such as Kawasaki Disease (KD) or severe bacterial and viral infections is challenging due to overlapping clinical and laboratory features. We aimed to determine a set of plasma protein biomarkers that could discriminate MIS-C from those other diseases. MethodsSeven candidate protein biomarkers for MIS-C were selected based on literature and from whole blood RNA-Sequencing data from patients with MIS-C and other diseases. Plasma concentrations of ARG1, CCL20, CD163, CORIN, CXCL9, PCSK9 and ADAMTS2 were quantified in MIS-C (n=22), KD (n=23), definite bacterial (DB; n=28) and viral (DV, n=27) disease, and healthy controls (n=8). Logistic regression models were used to determine the discriminatory ability of individual proteins and protein combinations to identify MIS-C, and association with severity of illness. ResultsPlasma levels of CD163, CXCL9, and PCSK9 were significantly elevated in MIS-C with a combined AUC of 86% (95% CI: 76.8%-95.1%) for discriminating MIS-C from other childhood diseases. Lower ARG1 and CORIN plasma levels were significantly associated with severe MIS-C cases requiring oxygen, inotropes or with shock. ConclusionOur findings demonstrate the feasibility of a host protein biomarker signature for MIS-C and may provide new insight into its pathophysiology.\nOne-Year Follow-up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein-Barr Virus\nAuthors: Pricoco, R.; Meidel, P.; Hofberger, T.; Zietemann, H.; Mueller, Y.; Wiehler, K.; Michel, K.; Paulick, J.; Leone, A.; Haegele, M.; Mayer-Huber, S.; Gerrer, K.; Mittelstrass, K.; Scheibenbogen, C.; Renz-Polster, H.; Mihatsch, L.; Behrends, U.\nScore: 65.5, Published: 2023-07-27 DOI: 10.1101/2023.07.24.23293082\nBackgroundInfectious mononucleosis, caused by the Epstein-Barr Virus (EBV-IM), has been linked to the development of myalgic encephalomyelitis/chronic fatigue-syndrome (ME/CFS) in children, adolescents, and young adults. Our study presents the first cohort of young individuals in Germany who were diagnosed with ME/CFS following EBV-IM. MethodsWe conducted a one-year follow-up of 25 young people diagnosed with ME/CFS at our specialized tertiary outpatient service by clinical criteria requiring post-exertional malaise and with documented EBV-IM as the triggering event. Demographic information, laboratory findings, frequency and severity of symptoms, physical functioning, and health-related quality of life (HRQoL) were assessed at first visit as well as 6 and 12 months later at follow-up visits. ResultsThe physical functioning and HRQoL of the cohort were significantly impaired, with young adults displaying more severe symptoms, as well as worsening of fatigue, physical and mental functioning, and HRQoL throughout the study, compared to adolescents. After one year, we found that 6/12 (54%) adolescents no longer met the diagnostic criteria for ME/CFS, indicating partial remission, while all young adults continued to fulfill the Canadian consensus criteria. Improvement in children was evident in physical functioning, symptom frequency and severity, and HRQoL, while young adults had little improvement. EBV serology and EBV DNA load did not correlate with distinct clinical features of ME/CFS, and clinical chemistry showed no evidence of inflammation. Remarkably, the median time from symptom onset to ME/CFS diagnosis was 13.8 (IQR: 9.1-34.9) months. ConclusionsME/CFS following EBV-IM in young people is a severely debilitating disease with diagnoses protracted longer than one year in many patients and only limited responses to conventional symptom-oriented medical care. Although younger children may have a better prognosis, their condition can fluctuate and significantly impact their HRQoL. Our data emphasize that biomarkers and effective therapeutic options are also urgently needed for this very young age group to better manage their medical condition and pave the way to recovery.\n",
  "wordCount" : "706",
  "inLanguage": "en",
  "datePublished": "2023-08-09T10:39:33Z",
  "dateModified": "2023-08-09T10:39:33Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/pediatrics/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      pediatrics
    </h1>
    <div class="post-meta"><span>updated on August 9, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.28.23293197">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.28.23293197" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.28.23293197">
        <p class="paperTitle">Plasma protein biomarkers distinguish Multisystem Inflammatory Syndrome in Children (MIS-C) from other pediatric infectious and inflammatory diseases</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.28.23293197" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.28.23293197" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Yeoh, S.; Estrada-Rivadeneyra, D.; Jackson, H.; Keren, I.; Galassini, R.; Cooray, S.; Shah, P.; Agyeman, P.; Basmaci, R.; Carrol, E.; Emonts, M.; Fink, C.; Kuijpers, T.; Martinon-Torres, F.; Mommert-Tripon, M.; Paulus, S.; Pokorn, M.; Rojo, P.; Romani, L.; Schlapbach, L.; Schweintzger, N.; Shen, C.-F.; Tsolia, M.; Usuf, E.; van der Flier, M.; Vermont, C.; von Both, U.; Yeung, S.; Zavadska, D.; Coin, L. J. M.; Cunnington, A. J.; Herberg, J.; Levin, M.; Kaforou, M.; Hamilton, M. S.; PERFORM Consortium,  ; DIAMONDS Consortium,  ; UK KD Genetic Consortium,  </p>
        <p class="info">Score: 14.6, Published: 2023-07-31 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.28.23293197' target='https://doi.org/10.1101/2023.07.28.23293197'> 10.1101/2023.07.28.23293197</a></p>
        <p class="abstract">BackgroundMultisystem inflammatory syndrome in children (MIS-C) is a rare but serious hyperinflammatory complication following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The mechanisms underpinning the pathophysiology of MIS-C are poorly understood. Moreover, clinically distinguishing MIS-C from other childhood infectious and inflammatory conditions, such as Kawasaki Disease (KD) or severe bacterial and viral infections is challenging due to overlapping clinical and laboratory features. We aimed to determine a set of plasma protein biomarkers that could discriminate MIS-C from those other diseases.

MethodsSeven candidate protein biomarkers for MIS-C were selected based on literature and from whole blood RNA-Sequencing data from patients with MIS-C and other diseases. Plasma concentrations of ARG1, CCL20, CD163, CORIN, CXCL9, PCSK9 and ADAMTS2 were quantified in MIS-C (n=22), KD (n=23), definite bacterial (DB; n=28) and viral (DV, n=27) disease, and healthy controls (n=8). Logistic regression models were used to determine the discriminatory ability of individual proteins and protein combinations to identify MIS-C, and association with severity of illness.

ResultsPlasma levels of CD163, CXCL9, and PCSK9 were significantly elevated in MIS-C with a combined AUC of 86% (95% CI: 76.8%-95.1%) for discriminating MIS-C from other childhood diseases. Lower ARG1 and CORIN plasma levels were significantly associated with severe MIS-C cases requiring oxygen, inotropes or with shock.

ConclusionOur findings demonstrate the feasibility of a host protein biomarker signature for MIS-C and may provide new insight into its pathophysiology.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.24.23293082">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.24.23293082" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.24.23293082">
        <p class="paperTitle">One-Year Follow-up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein-Barr Virus</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.24.23293082" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.24.23293082" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Pricoco, R.; Meidel, P.; Hofberger, T.; Zietemann, H.; Mueller, Y.; Wiehler, K.; Michel, K.; Paulick, J.; Leone, A.; Haegele, M.; Mayer-Huber, S.; Gerrer, K.; Mittelstrass, K.; Scheibenbogen, C.; Renz-Polster, H.; Mihatsch, L.; Behrends, U.</p>
        <p class="info">Score: 65.5, Published: 2023-07-27 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.24.23293082' target='https://doi.org/10.1101/2023.07.24.23293082'> 10.1101/2023.07.24.23293082</a></p>
        <p class="abstract">BackgroundInfectious mononucleosis, caused by the Epstein-Barr Virus (EBV-IM), has been linked to the development of myalgic encephalomyelitis/chronic fatigue-syndrome (ME/CFS) in children, adolescents, and young adults. Our study presents the first cohort of young individuals in Germany who were diagnosed with ME/CFS following EBV-IM.

MethodsWe conducted a one-year follow-up of 25 young people diagnosed with ME/CFS at our specialized tertiary outpatient service by clinical criteria requiring post-exertional malaise and with documented EBV-IM as the triggering event. Demographic information, laboratory findings, frequency and severity of symptoms, physical functioning, and health-related quality of life (HRQoL) were assessed at first visit as well as 6 and 12 months later at follow-up visits.

ResultsThe physical functioning and HRQoL of the cohort were significantly impaired, with young adults displaying more severe symptoms, as well as worsening of fatigue, physical and mental functioning, and HRQoL throughout the study, compared to adolescents. After one year, we found that 6/12 (54%) adolescents no longer met the diagnostic criteria for ME/CFS, indicating partial remission, while all young adults continued to fulfill the Canadian consensus criteria. Improvement in children was evident in physical functioning, symptom frequency and severity, and HRQoL, while young adults had little improvement. EBV serology and EBV DNA load did not correlate with distinct clinical features of ME/CFS, and clinical chemistry showed no evidence of inflammation. Remarkably, the median time from symptom onset to ME/CFS diagnosis was 13.8 (IQR: 9.1-34.9) months.

ConclusionsME/CFS following EBV-IM in young people is a severely debilitating disease with diagnoses protracted longer than one year in many patients and only limited responses to conventional symptom-oriented medical care. Although younger children may have a better prognosis, their condition can fluctuate and significantly impact their HRQoL. Our data emphasize that biomarkers and effective therapeutic options are also urgently needed for this very young age group to better manage their medical condition and pave the way to recovery.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
